Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy

13Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Individuals who are heterozygous for the CCR5-Δ32 mutation provide a natural model to examine the effects of reduced CCR5 expression on human immunodeficiency virus (HIV) persistence. We evaluated the HIV reservoir in 18 CCR5-Δ32 heterozygotes and 54 CCR5 wild-type individuals during suppressive antiretroviral therapy. Cell-associated HIV RNA levels (P =.035), RNA to DNA transcriptional ratios (P =.013), and frequency of detectable HIV 2-long terminal repeat circular DNA (P =.013) were significantly lower in CD4+ T cells from CCR5-Δ32 heterozygotes. Cell-associated HIV RNA was significantly correlated with CCR5 surface expression on CD4+ T cells (r2 = 0.136; P =.002). Our findings suggest that curative strategies should further explore manipulation of CCR5.

Cite

CITATION STYLE

APA

Wang, C., Abdel-Mohsen, M., Strain, M. C., Lada, S. M., Yukl, S., Cockerham, L. R., … Pillai, S. K. (2014). Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy. Journal of Infectious Diseases, 210(11), 1838–1843. https://doi.org/10.1093/infdis/jiu338

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free